Desq Long
Sign in

Company

Skye Bioscience, Inc.

SKYE · CIK 0001516551

SEC FORM 4
$184,910.11

Skye Bioscience, Inc. (SKYE)

Sale of 114,851 shares at $1.61 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001231919-26-001224 · filed 2026-09-24 · View filing →

SEC FORM 4
$7,290.08

Skye Bioscience, Inc. (SKYE)

Sale of 4,528 shares at $1.61 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001231919-26-001224 · filed 2026-09-24 · View filing →

SEC FORM 4
$184,910.11

Skye Bioscience, Inc. (SKYE)

Sale of 114,851 shares at $1.61 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001598549-26-000015 · filed 2026-09-24 · View filing →

SEC FORM 4
$7,290.08

Skye Bioscience, Inc. (SKYE)

Sale of 4,528 shares at $1.61 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Sep 23, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001598549-26-000015 · filed 2026-09-24 · View filing →

SEC FORM 4
$45,559.80

Skye Bioscience, Inc. (SKYE)

Sale of 27,612 shares at $1.65 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001231919-26-001224 · filed 2026-09-24 · View filing →

SEC FORM 4
$1,795.20

Skye Bioscience, Inc. (SKYE)

Sale of 1,088 shares at $1.65 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001231919-26-001224 · filed 2026-09-24 · View filing →

SEC FORM 4
$45,559.80

Skye Bioscience, Inc. (SKYE)

Sale of 27,612 shares at $1.65 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001598549-26-000015 · filed 2026-09-24 · View filing →

SEC FORM 4
$1,795.20

Skye Bioscience, Inc. (SKYE)

Sale of 1,088 shares at $1.65 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001598549-26-000015 · filed 2026-09-24 · View filing →

SEC FORM 4
$62,279.37

Skye Bioscience, Inc. (SKYE)

Sale of 32,607 shares at $1.91 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001231919-26-001197 · filed 2026-09-18 · View filing →

SEC FORM 4
$2,454.35

Skye Bioscience, Inc. (SKYE)

Sale of 1,285 shares at $1.91 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001231919-26-001197 · filed 2026-09-18 · View filing →

SEC FORM 4
$62,279.37

Skye Bioscience, Inc. (SKYE)

Sale of 32,607 shares at $1.91 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001598549-26-000013 · filed 2026-09-18 · View filing →

SEC FORM 4
$2,454.35

Skye Bioscience, Inc. (SKYE)

Sale of 1,285 shares at $1.91 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001598549-26-000013 · filed 2026-09-18 · View filing →

SEC FORM 4
$370.88

Skye Bioscience, Inc. (SKYE)

Sale of 1,159 shares at $0.32 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001231919-26-000959 · filed 2026-08-20 · View filing →

SEC FORM 4
$14.72

Skye Bioscience, Inc. (SKYE)

Sale of 46 shares at $0.32 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001231919-26-000959 · filed 2026-08-20 · View filing →

SEC FORM 4
$2,078.40

Skye Bioscience, Inc. (SKYE)

Sale of 6,495 shares at $0.32 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001231919-26-000959 · filed 2026-08-20 · View filing →

SEC FORM 4
$370.88

Skye Bioscience, Inc. (SKYE)

Sale of 1,159 shares at $0.32 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001598549-26-000005 · filed 2026-08-20 · View filing →

SEC FORM 4
$14.72

Skye Bioscience, Inc. (SKYE)

Sale of 46 shares at $0.32 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001598549-26-000005 · filed 2026-08-20 · View filing →

SEC FORM 4
$2,078.40

Skye Bioscience, Inc. (SKYE)

Sale of 6,495 shares at $0.32 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Aug 20, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001598549-26-000005 · filed 2026-08-20 · View filing →

SEC FORM 4
$3,589.25

Skye Bioscience, Inc. (SKYE)

Sale of 10,255 shares at $0.35 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001231919-26-000959 · filed 2026-08-20 · View filing →

SEC FORM 4
$143.15

Skye Bioscience, Inc. (SKYE)

Sale of 409 shares at $0.35 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001231919-26-000959 · filed 2026-08-20 · View filing →

SEC FORM 4
$20,116.60

Skye Bioscience, Inc. (SKYE)

Sale of 57,476 shares at $0.35 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001231919-26-000959 · filed 2026-08-20 · View filing →

SEC FORM 4
$3,589.25

Skye Bioscience, Inc. (SKYE)

Sale of 10,255 shares at $0.35 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001598549-26-000005 · filed 2026-08-20 · View filing →

SEC FORM 4
$143.15

Skye Bioscience, Inc. (SKYE)

Sale of 409 shares at $0.35 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001598549-26-000005 · filed 2026-08-20 · View filing →

SEC FORM 4
$20,116.60

Skye Bioscience, Inc. (SKYE)

Sale of 57,476 shares at $0.35 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Aug 19, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001598549-26-000005 · filed 2026-08-20 · View filing →

SEC FORM 4
$17,134.20

Skye Bioscience, Inc. (SKYE)

Sale of 45,090 shares at $0.38 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001231919-26-000959 · filed 2026-08-20 · View filing →

SEC FORM 4
$695.40

Skye Bioscience, Inc. (SKYE)

Sale of 1,830 shares at $0.38 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001231919-26-000959 · filed 2026-08-20 · View filing →

SEC FORM 4
$96,170.40

Skye Bioscience, Inc. (SKYE)

Sale of 253,080 shares at $0.38 per share.

Reporting Persons 5AM Partners VII, LLC · 5AM Ventures VII, L.P. · 5AM Partners II, LLC · 5AM Ventures II LP · 5AM CO-INVESTORS II LP · DIEKMAN JOHN D · PARMAR KUSH · ROCKLAGE SCOTT M · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001231919-26-000959 · filed 2026-08-20 · View filing →

SEC FORM 4
$17,134.20

Skye Bioscience, Inc. (SKYE)

Sale of 45,090 shares at $0.38 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001598549-26-000005 · filed 2026-08-20 · View filing →

SEC FORM 4
$695.40

Skye Bioscience, Inc. (SKYE)

Sale of 1,830 shares at $0.38 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001598549-26-000005 · filed 2026-08-20 · View filing →

SEC FORM 4
$96,170.40

Skye Bioscience, Inc. (SKYE)

Sale of 253,080 shares at $0.38 per share.

Reporting Person Schwab Andrew J. · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001598549-26-000005 · filed 2026-08-20 · View filing →